
BMY
Bristol-Myers Squibb Co.
$78.68
Open: $79.11 High: $80.59 Low: $78.17 Close: $79.887
Range: 2022-06-27 - 2022-06-28
Volume:4,014,175Market: Open
Powered by Finage Stock APIDelayed data
BMY
Bristol-Myers Squibb Co. 430 E. 29TH STREET https://www.bms.com
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.- CEO: Giovanni Caforio
- Employees: 32,200
- Sector: Healthcare
- Industry: Drug Manufacturers
BMY News
Latest news about the BMY
- 7 Biotech Stocks to Buy With Key Catalysts for April by Investor Place at 4/5/22, 12:00 AMView More →
- 7 Michael Burry Stocks to Buy as 'The Big Short' Investor Makes Moves by Investor Place at 3/17/22, 12:00 AMView More →